Judges' dueling decisions put access to a key abortion drug in jeopardy nationwide

Judges' dueling decisions put access to a key abortion drug in jeopardy nationwide
Federal judges in two states issued contradictory decisions Friday evening that could drastically impact access to a drug used in nearly all medication abortions in the U.S.

In Texas, U.S. District Judge Matthew Kacsmaryk ruled that the Food and Drug Administration improperly approved the abortion pill mifepristone more than 20 years ago. A coalition of anti-abortion rights groups called the Alliance for Hippocratic Medicine sued the FDA last year. The judge ordered to FDA to stay its approval and gave the government seven days to seek relief from an appeals court.